{
    "root": "9f7087f5-c8ef-4c1f-9a25-228ed3149b01",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "Aripiprazole"
    },
    "value": "20250311",
    "ingredients": [
        {
            "name": "ARIPIPRAZOLE",
            "code": "82VFR53I78"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FD&C BLUE NO. 2",
            "code": "L06K8R7DQK"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        }
    ],
    "indications": "aripiprazole tablets indicated treatment : schizophrenia irritability associated autistic disorder treatment tourette ’ disorder",
    "contraindications": "administer daily without regard meals ( 2 ) initial dose recommended dose maximum dose schizophrenia – adults ( 2.1 ) 10 15 mg/day 10 15 mg/day 30 mg/day schizophrenia – adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day irritability associated autistic disorder – pediatric patients ( 2.4 ) 2 mg/day 5 10 mg/day 15 mg/day tourette ’ disorder - ( 2.5 ) patients < 50 kg 2 mg/day 5 mg/day 10 mg/day patients ≥50 kg 2 mg/day 10 mg/day 20 mg/day known cyp2d6 poor metabolizers : half usual dose ( 2.6 )",
    "warningsAndPrecautions": "supplied aripiprazole tablets usp 2 mg green colored , modified rectangular shaped , uncoated tablets debossed ‘ 61 ’ one side ‘ h ’ side . bottles 30 ndc 65862-661-30 bottles 100 ndc 65862-661-01 bottles 500 ndc 65862-661-05 10 x 10 unit-dose tablets ndc 65862-661-78 aripiprazole tablets usp 5 mg blue colored , modified rectangular shaped , uncoated tablets debossed ‘ 62 ’ one side ‘ h ’ side . bottles 30 ndc 65862-662-30 bottles 100 ndc 65862-662-01 bottles 500 ndc 65862-662-05 10 x 10 unit-dose tablets ndc 65862-662-78 aripiprazole tablets usp 10 mg white colored , modified rectangular shaped , uncoated tablets debossed ‘ 63 ’ one side ‘ h ’ side . bottles 30 ndc 65862-663-30 bottles 100 ndc 65862-663-01 bottles 500 ndc 65862-663-05 10 x 10 unit-dose tablets ndc 65862-663-78 aripiprazole tablets usp 15 mg white colored , round shaped , uncoated tablets debossed ‘ 64 ’ one side ‘ h ’ side . bottles 30 ndc 65862-664-30 bottles 100 ndc 65862-664-01 bottles 500 ndc 65862-664-05 10 x 10 unit-dose tablets ndc 65862-664-78 aripiprazole tablets usp 20 mg white colored , round shaped , uncoated tablets debossed ‘ 65 ’ one side ‘ h ’ side . bottles 30 ndc 65862-665-30 bottles 100 ndc 65862-665-01 bottles 500 ndc 65862-665-05 10 x 10 unit-dose tablets ndc 65862-665-78 aripiprazole tablets usp 30 mg white colored , round shaped , uncoated tablets debossed ‘ 66 ’ one side ‘ h ’ side . bottles 30 ndc 65862-666-30 bottles 100 ndc 65862-666-01 bottles 500 ndc 65862-666-05 10 x 10 unit-dose tablets ndc 65862-666-78 storage store 20º 25ºc ( 68º 77ºf ) [ usp controlled room temperature ] .",
    "adverseReactions": "aripiprazole tablets contraindicated patients history hypersensitivity reaction aripiprazole . ranged pruritus/urticaria anaphylaxis [ ( 6.2 ) ] .",
    "indications_original": "Aripiprazole tablets are indicated for the treatment of:\n                  \n                  \n                     Schizophrenia\n                     Irritability Associated with Autistic Disorder\n                     Treatment of Tourette’s Disorder",
    "contraindications_original": "Administer once daily without regard to meals ( 2 ) Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults ( 2.1 ) 10 to 15 mg/day 10 to 15 mg/day 30 mg/day Schizophrenia – adolescents ( 2.1 ) 2 mg/day 10 mg/day 30 mg/day Irritability associated with autistic disorder – pediatric patients ( 2.4 ) 2 mg/day 5 to 10 mg/day 15 mg/day Tourette’s Disorder - ( 2.5 ) Patients <50 kg 2 mg/day 5 mg/day 10 mg/day Patients ≥50 kg 2 mg/day 10 mg/day 20 mg/day Known CYP2D6 poor metabolizers: Half of the usual dose ( 2.6 )",
    "warningsAndPrecautions_original": "How Supplied\n                  \n                  \n                  \n                     Aripiprazole Tablets USP 2 mg are green colored, modified rectangular shaped, uncoated tablets debossed with ‘61’ on one side and ‘H’ on other side.\n                  \n                              Bottles of 30                           NDC 65862-661-30\n                              Bottles of 100                         NDC 65862-661-01\n                              Bottles of 500                         NDC 65862-661-05\n                              10 x 10 Unit-dose Tablets       NDC 65862-661-78 \n                  \n                  \n                     Aripiprazole Tablets USP 5 mg are blue colored, modified rectangular shaped, uncoated tablets debossed with ‘62’ on one side and ‘H’ on other side.\n                  \n                              Bottles of 30                           NDC 65862-662-30\n                              Bottles of 100                         NDC 65862-662-01\n                              Bottles of 500                         NDC 65862-662-05\n                              10 x 10 Unit-dose Tablets       NDC 65862-662-78 \n                  \n                  \n                     Aripiprazole Tablets USP 10 mg are white colored, modified rectangular shaped, uncoated tablets debossed with ‘63’ on one side and ‘H’ on other side.\n                  \n                              Bottles of 30                           NDC 65862-663-30\n                              Bottles of 100                         NDC 65862-663-01\n                              Bottles of 500                         NDC 65862-663-05\n                              10 x 10 Unit-dose Tablets       NDC 65862-663-78 \n                  \n                  \n                     Aripiprazole Tablets USP 15 mg are white colored, round shaped, uncoated tablets debossed with ‘64’ on one side and ‘H’ on other side.\n                  \n                              Bottles of 30                           NDC 65862-664-30\n                              Bottles of 100                         NDC 65862-664-01\n                              Bottles of 500                         NDC 65862-664-05\n                              10 x 10 Unit-dose Tablets       NDC 65862-664-78 \n                  \n                  \n                     Aripiprazole Tablets USP 20 mg are white colored, round shaped, uncoated tablets debossed with ‘65’ on one side and ‘H’ on other side.\n                  \n                              Bottles of 30                           NDC 65862-665-30\n                              Bottles of 100                         NDC 65862-665-01\n                              Bottles of 500                         NDC 65862-665-05\n                              10 x 10 Unit-dose Tablets       NDC 65862-665-78 \n                  \n                  \n                     Aripiprazole Tablets USP 30 mg are white colored, round shaped, uncoated tablets debossed with ‘66’ on one side and ‘H’ on other side.\n                  \n                              Bottles of 30                           NDC 65862-666-30\n                              Bottles of 100                         NDC 65862-666-01\n                              Bottles of 500                         NDC 65862-666-05\n                              10 x 10 Unit-dose Tablets       NDC 65862-666-78 \n                  \n                      \n                  \n                  \n                     Storage\n                  \n                  \n                  Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Aripiprazole tablets are contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. Reactions have ranged from pruritus/urticaria to anaphylaxis [see Adverse Reactions (6.2)]."
}